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Background: Both indices of obesity and lipoprotein subfractions contribute to coronary heart disease risk.
However, associations between indices of obesity and lipoprotein subfractions remain undetermined across
different ethnic groups.
Objective: This study aims to examine the associations of indices of obesity in Japanese Americans, African
Americans, and Koreans with lipoprotein subfractions.
Methods: A population-based sample of 230 Japanese American, 91 African American, and 291 Korean men
ages 40 to 49 was examined for indices of obesity—that is, visceral and subcutaneous adipose tissue (VAT and
SAT, respectively); waist circumference; and body mass index—and for lipoprotein subfractions by nuclear
magnetic resonance spectroscopy. Multiple regression analyses were performed in each of the 3 ethnic groups
to examine the associations of each index of obesity with lipoprotein.
Conclusions: VAT had signiﬁcant positive associations with total and small low-density lipoprotein (LDL) and
a signiﬁcant negative association with large high-density lipoprotein (HDL) in all 3 ethnicities (p < 0.01). SAT,
waist circumference, and body mass index had signiﬁcant positive associations with total and small LDL in
only Japanese Americans and Koreans, whereas these indices had signiﬁcant inverse associations with large
HDL in all ethnic groups (p < 0.01). Compared with SAT, VAT had larger R2 values in the associations with
total and small LDL and large HDL in all 3 ethnic groups. VAT is signiﬁcantly associated with total and small
LDL and large HDL in all 3 ethnic groups. The associations of SAT, waist circumference, and body mass index
with lipoprotein subfractions are weaker than the associations of VAT in all 3 ethnic groups.School of Public Health,
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CC BY-NC-ND license.Coronary heart disease (CHD) is the leading cause of
death in the United States [1] and worldwide [2]. Thus,
preventing CHD is of great interest from both a clinical and
a public health perspective. Current clinical practice
guidelines, such as those by the National Cholesterol Ed-
ucation Program Adult Treatment Panel, recommend
measuring standard lipids to assess CHD risk and stratify
risk categories [3]. Our ability to estimate the risk of
developing CHD is limited, however, and intense efforts
have been made to determine whether additional exami-
nation would improve the accuracy of CHD risk estimation
[4,5]. Such efforts include measuring lipoprotein
subfractions.
Lipoprotein subfractions can be quantiﬁed by nuclear
magnetic resonance spectroscopy [6,7]. Some subfractions
are reported to be associated with CHD. Total low-density
lipoprotein (LDL) number and small LDL particles, forGLOBAL HEART, VOL. 8, NO. 3, 2013
September 2013: 273-280example, are strong predictors of CHD. Small high-density
lipoprotein (HDL) is positively associated with CHD,
whereas large HDL is inversely associated [8,9].
Many epidemiological studies have demonstrated
strong associations of indices of obesity, such as visceral
adipose tissue (VAT), subcutaneous adipose tissue (SAT),
waist circumference (WC), and body mass index (BMI),
with CHD and its risk factors [10e12]. Evidence suggests
body fat distribution, such as VAT, is more strongly asso-
ciated with CHD than BMI or WC are [11,13].
Recently, several studies have examined the associa-
tions between indices of obesity and lipoprotein sub-
fractions. In these studies, VAT is more strongly associated
with risk factors and lipoprotein subfractions than SAT is
[11,14]. We have reported that VAT and SAT are associ-
ated with higher particle concentrations of total, large, and
medium very low-density lipoprotein (VLDL), small LDL,273
j gSCIENCE
274and large HDL in a population-based sample of U.S. white
and Japanese middle-aged men [15]. Our study also in-
dicates the associations of VAT with lipoprotein sub-
fractions are stronger than those for SAT. However,
few studies have investigated associations between indices
of obesity (i.e., VAT, SAT, WC, and BMI) and lipoprotein
subfractions among different ethnicity groups from a
community-based population. This study examined
the association between indices of obesity and lipoprotein
;subfractions for Japanese Americans (JA), African Ameri-
cans (AA), and Koreans from a community-based sample.
METHODS
Study participants
During 2002 to 2006, 712 men ages 40 to 49 were
randomly selected: 303 JA men from a representative
sample of offspring to fathers who participated in the
Honolulu Heart Program, Honolulu, Hawaii, USA [16];
107 AA men from Allegheny County, Pennsylvania, USA
[17]; and 302 Korean men from Ansan, Gyeonggi-do,
South Korea. JA men were the third or fourth generation
of JA without ethnic admixture. All the participants were
without clinical cardiovascular disease or other severe
diseases [17]. Men in Honolulu were randomly selected
from the offspring of the members of the Honolulu Heart
Program [18]. Men in Allegheny County, Pennsylvania,
USA, were randomly selected from the voter registration
list. The voter registration list is very complete. Men in
South Korea were randomly selected from the Korean
Health and Genome Study, an ongoing population-based
prospective cohort study [19]. The rate of participation
was about 50% at each site. This rate of participation
is much higher than for the MESA (Multi-Ethnic Study
of Atherosclerosis) [20] and is comparable with the CAR-
DIA (Coronary Artery Risk Development in Young Adults)
[21] and the CHS (Cardiovascular Health Study) [22].
Of the original sample, we excluded men taking lipid-
lowering medications (n ¼ 83) and individuals with
missing values (n ¼ 17). The ﬁnal sample was 612 subjects
(230 JA, 91 AA, and 291 Koreans). Written informed con-
sent was obtained from each participant. The study was
approved by the institutional review boards of the following
institutions: the Kuakini Medical Center, Honolulu, Hawaii,
USA; the University of Pittsburgh, Pittsburgh, Pennsylvania,
USA; and Korea University, Seoul, South Korea.
All participants underwent a physical examination and
laboratory assessment and completed a lifestyle question-
naire (e.g., smoking and alcohol consumption), as
described previously [17]. Venipuncture was performed
after a 12-h fast, early in the morning of the clinic visit.
Samples were stored at 80C and shipped on dry ice to
the University of Pittsburgh to determine lipids, glucose,
and other factors. Serum lipids were determined using
standardized methods by the Centers for Disease Control
and Prevention. Intra-assay coefﬁcients of variation for total
cholesterol, triglycerides, and HDL-C were 1.8%, 1.8%,and 3.5%, respectively. Serum glucose was determined by
an enzymatic assay. An intra-assay coefﬁcient of variation
for glucose was 1.8%. Data collection was standardized
across the research centers.
Body mass index and abdominal adiposity indices
BMI was calculated using body weight and height (kg/m2).
WC was measured twice at the umbilical level using a
measuring tape while the participant was standing upright
in underwear. An average of the 2 measurements was used.
VAT and SAT were determined as previously described
[23]. Brieﬂy, VAT and SAT areas were measured at the level
between the fourth and ﬁfth lumbar vertebrae using
computed tomography images obtained with the same
apparatus at each site (GE-Imatron C150; GE Medical
System, South San Francisco, California, USA). All
computed tomography images were read at the Cardio-
vascular Institute, University of Pittsburgh, using image
analysis software by 1 trained reader (AccuImage; Accu-
Image Diagnostic Corporation, San Francisco, California,
USA).
Lipoprotein measurement
Nuclear magnetic resonance spectroscopy (LipoScience,
Inc., Raleigh, North Carolina, USA) was performed to
quantify serum lipoproteins of different sizes [24]. Particle
concentrations of the following lipoproteins were deter-
mined: VLDL (large: >60 nm; medium: 35e60 nm; small:
27e35 nm); LDL (intermediate-density lipoprotein:
23e27 nm; large: 21.3e23 nm; small: 18.3e21.2 nm);
and HDL (large: 8.8e13.0 nm; medium: 8.2e8.8 nm;
small: 7.3e8.2 nm) [8]. Weighted average particle sizes
were calculated from the subclass levels.
Statistical analyses
Values of lipoprotein subfractions were positively skewed
and log-transformed to approximate the normality. To
examine the correlations among obesity indices, we used
the Spearman rank correlation. To examine the association
of each obesity index— BMI, WC, SAT, and VAT (a pri-
mary predictor variable)—with each lipoprotein (an
outcome variable), multiple linear regression analyses were
performed. In the regression model, values of lipoprotein
were log-transformed to approximate the normality, and
age, pack-year smoking, and amount of alcohol con-
sumption per day were adjusted. Statistical signiﬁcance
level was considered to be 0.01. All statistical analyses were
performed with IBM SPSS Statistics (version 20, IBM,
Armonk, New York, USA).
RESULTS
The baseline characteristics of study subjects are presented
in Table 1. Mean BMI (kg/m2) differed signiﬁcantly
among the 3 groups: 27.3 for JA; 29.6 for AA; and 24.7 for
Koreans. JA had signiﬁcantly higher VAT and serumGLOBAL HEART, VOL. 8, NO. 3, 2013
September 2013: 273-280
TABLE 1. Basic characteristics of the study participants during 2002 to 2006 (N ¼ 612)
Japanese Americans African Americans Koreans p Value
n 230 91 291
Age, yrs 46.0  2.9 (45.7, 46.4) 44.7  2.8 (44.1, 45.2) 44.8  2.8 (44.4, 45.1) <0.001*y
BMI, kg/m2 27.3  4.0 (26.8, 27.8) 29.6  5.9 (28.4, 30.8) 24.7  2.7 (24.4, 25.0) <0.001*yz
WC, cm 92.2  10.2 (90.8, 93.4) 98.9  13.4 (96.1, 101.6) 83.4  7.1 (82.6, 84.2) <0.001*yz
VAT, cm2 97.5  39.0 (92.3, 102.5) 79.7  36.7 (72.1, 87.4) 77.9  28.5 (74.6, 81.2) <0.001*y
SAT, cm2 131.0  56.6 (123.4, 138.2) 168.1  91.2 (149.1, 187.1) 82.8  31.6 (79.1, 86.4) <0.001*yz
Systolic BP, mm Hg 126.5  12.1 (124.9, 128.0) 127.1  16.5 (123.6, 130.5) 121.8  14.1 (120.1, 123.4) <0.001*z
Diastolic BP, mm Hg 76.8  8.7 (75.7, 78.0) 75.4  12.5 (72.8, 78.0) 76.3  11.1 (75.0, 77.6) NS
Type 2 DM 7.4 (17) 8.8 (8) 9.6 (28) NS
Smoking, pack-years 4.5  9.3 (3.3, 5.8) 4.8  7.6 (3.3, 6.4) 14.1  14.1 (12.5, 15.8) <0.001*z
Alcohol, g/day 16.6  28.3 (12.9, 20.3) 14.0  22.8 (9.3, 18.8) 21.7  32.6 (17.9, 25.4) <0.05z
Total cholesterol, mmol/l 5.49  0.93 (5.36, 5.59) 5.35  1.20 (5.10, 5.60) 4.99  0.87 (4.90, 5.10) <0.001*z
Triglycerides, mmol/l 1.99  1.44 (1.80, 2.17) 1.52  0.85 (1.34, 1.69) 1.83  1.19 (1.69, 1.97) <0.01y
LDL-C, mmol/l 3.31  0.84 (3.20, 3.40) 3.33  1.08 (3.10, 3.56) 2.99  0.81 (2.90, 3.09) <0.001*z
HDL-C, mmol/l 1.31  0.32 (1.27, 1.35) 1.32  0.41 (1.24, 1.41) 1.19  0.30 (1.15, 1.22) <0.001*z
Lipoprotein subfractions, log-transformed
VLDL particle
Total, nmol/l 1.99  0.22 (1.96, 2.02) 1.81  0.29 (1.75, 1.87) 1.82  0.26 (1.79, 1.85) <0.001*y
Large, nmol/l 0.57  0.43 (0.52, 0.63) 0.49  0.33 (0.42, 0.56) 0.37  0.42 (0.33, 0.43) 0.001*yz
Medium, nmol/l 1.60  0.37 (1.55, 1.65) 1.29  0.49 (1.20, 1.40) 1.27  0.57 (1.22, 1.35) <0.001*y
Small, nmol/l 1.66  0.25 (1.62, 1.69) 1.59  0.25 (1.53, 1.64) 1.53  0.30 (1.50, 1.57) <0.001*
Average size, nm 1.69  0.06 (1.69, 1.70) 1.71  0.06 (1.70, 1.72) 1.66  0.08 (1.65, 1.67) <0.001*z
LDL particle
Total, nmol/l 3.13  0.14 (3.10, 3.14) 3.15  0.14 (3.11, 3.17) 3.05  0.14 (3.03, 3.06) <0.001*z
IDL, nmol/l 1.53  0.70 (1.45, 1.63) 1.64  0.54 (1.52, 1.75) 0.99  0.73 (0.91, 1.08) <0.001*z
Large, nmol/l 2.38  0.46 (2.31, 2.43) 2.60  0.33 (2.52, 2.67) 2.59  0.28 (2.56, 2.62) <0.001*y
Small, nmol/l 2.87  0.51 (2.80, 2.93) 2.86  0.42 (2.76, 2.94) 2.64  0.61 (2.58, 2.72) <0.001*z
Average size, nm 1.33  0.02 (1.33, 1.34) 1.34  0.02 (1.33, 1.34) 1.34  0.02 (1.34, 1.34) <0.001*y
HDL particle
Total, nmol/l 1.56  0.12 (1.56, 1.57) 1.50  0.09 (1.48, 1.52) 1.46  0.08 (1.45, 1.47) <0.001*yz
Large, nmol/l 0.79  0.23 (0.77, 0.83) 0.76  0.25 (0.71, 0.81) 0.71  0.22 (0.69, 0.74) <0.001*
Medium, nmol/l 0.45  0.35 (0.41, 0.50) 0.22  0.27 (0.17, 0.28) 0.15  0.25 (0.12, 0.18) <0.001*y
Small, nmol/l 1.44  0.12 (1.43, 1.45) 1.40  0.10 (1.38, 1.42) 1.36  0.10 (1.35, 1.38) <0.001*yz
Average size, nm 0.99  0.02 (0.99, 0.99) 0.99  0.02 (0.98, 0.99) 0.99  0.02 (0.99, 0.99) NS
Values are means  SD for continuous variables and percentages for categorical variables. The p values for continuous variables were obtained from
analysis of variance and for categorical variables were from chi-square test. The 95% conﬁdence intervals are shown in parentheses for continuous
variables. BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HDL-C, high-density lipoprotein cholesterol; IDL, intermediate-density
lipoprotein; LDL-C, low-density lipoprotein cholesterol; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; VLDL, very low-density
lipoprotein; WC, waist circumference.
*Signiﬁcant between Japanese Americans and Koreans.
ySigniﬁcant between Japanese Americans and African Americans.
zSigniﬁcant between Koreans and African Americans.
gSCIENCEjtriglyceride levels. AA had signiﬁcantly higher BMI and
SAT. AA also had signiﬁcantly lower serum triglyceride
levels. Koreans had signiﬁcantly lower BMI, WC, and SAT.
Koreans also had signiﬁcantly lower serum total choles-
terol, LDL cholesterol, and HDL cholesterol levels. Average
concentrations or sizes of all the lipoprotein subfractions,
except for HDL cholesterol size, were signiﬁcantly different
among the 3 groups (Table 1).GLOBAL HEART, VOL. 8, NO. 3, 2013
September 2013: 273-280Correlations among VAT, SAT, WC, and BMI
Correlations among indices of obesity within the 3 groups
are shown in Table 2. In each of the 3 groups, SAT,
compared with VAT, was more highly correlated with BMI
and WC; the correlation between VAT and SAT was
weaker compared with the correlations of other combina-
tions; the correlation between BMI and WC was the
strongest in JA and Koreans.275
TABLE 2. Spearman rank correlations among indices of obesity for Japanese American, African American, and Korean men (N ¼ 612)
r (p < 0.001 for all)
Japanese Americans (n ¼ 230) African Americans (n ¼ 91) Koreans (n ¼ 291)
VAT SAT WC BMI VAT SAT WC BMI VAT SAT WC BMI
VAT 1.00 0.60 0.73 0.66 1.00 0.66 0.72 0.63 1.00 0.56 0.66 0.64
SAT 1.00 0.83 0.78 1.00 0.93 0.84 1.00 0.74 0.69
WC 1.00 0.89 1.00 0.90 1.00 0.80
BMI 1.00 1.00 1.00
Abbreviations as in Table 1.
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276Associations of LDL subfractions with VAT, SAT,
WC, and BMI
In each of the 3 groups, VAT was signiﬁcantly and posi-
tively associated with total and small LDL particle con-
centrations; VAT was signiﬁcantly and negatively
associated with LDL size (Table 3). However, the associa-
tions of SAT, WC, and BMI with LDL subfractions were
varied among the 3 groups. SAT, WC, and BMI were
signiﬁcantly associated with total and small LDL particle
concentrations in JA and Koreans, but no signiﬁcant as-
sociations were found in AA. In JA and Koreans, R2 values
for the associations of indices of obesity with total and
small LDL lipoprotein subfractions were different. BMI had
the largest R2 values (R2 ¼ 0.14, 0.12, 0.08, and 0.08 for
BMI, WC, VAT, and SAT) with total LDL particle con-
centrations. VAT had the largest R2 values (R2 ¼ 0.14,
0.14, 0.11, and 0.10 for VAT, WC, BMI, and SAT) with
small LDL particle concentrations in JA. However, VAT
had the largest R2 values (R2 ¼ 0.19, 0.10, 0.09, and 0.07
for VAT, BMI, WC, and SAT with total LDL particle con-
centrations; R2 ¼ 0.14, 0.06, 0.06, and 0.05 for VAT, BMI,
WC, and SAT with small LDL particle concentrations) in
the associations with both total and small LDL particle
concentrations in Koreans (Table 3).Associations of HDL subfractions with VAT, SAT,
WC, and BMI
VAT was signiﬁcantly and negatively associated with large
HDL and HDL size in each of the 3 groups (Table 4). SAT,
WC, and BMI were signiﬁcantly and negatively associated
with large HDL concentration and size of HDL in the 3
ethnicities. R2 values in the association between indices of
obesity with HDL lipoprotein subfractions were varied
among the ethnicities. For example, VAT had the larger R2
values in the associations of both large HDL concentration
and HDL size compared with those for SAT, WC, and BMI
in AA (R2 ¼ 0.22, 0.17, 0.15, and 0.11 for VAT, BMI, WC,
and SAT with large HDL particle concentrations; R2 ¼
0.15, 0.13, 0.11, and 0.11 for VAT, WC, BMI, and SAT
with HDL size) and in Koreans (R2 ¼ 0.15, 0.14, 0.12, and
0.12 for VAT, BMI, SAT, and SAT with large HDL particle
concentrations; R2 ¼ 0.23, 0.17, 0.16, and 0.12 for VAT,
BMI, WC, and SAT with HDL size). However, WC hadlarger R2 value than BMI, VAT, and SAT did (R2 ¼ 0.19,
0.18, 0.17, and 0.11 for WC, BMI, VAT, and SAT with
large HDL particle concentrations; R2 ¼ 0.29, 0.27, 0.25,
and 0.19 for WC, BMI, VAT, and SAT with HDL size) in JA
(Table 4).
Associations of VLDL subfractions with VAT, SAT,
WC, and BMI
In each of the 3 groups, VAT was signiﬁcantly associated
with large VLDL (Table 5). Varied but signiﬁcant associa-
tions of SAT, WC, and BMI with large VLDL were found
among the 3 groups. SAT, WC, and BMI were signiﬁcantly
and positively associated with large VLDL in JA and AA,
but only BMI was signiﬁcantly associated with large VLDL
in Koreans. SAT, WC, and BMI were variedly associated
with other VLDL lipoprotein subfractions. In the associa-
tion with large VLDL, VAT had the largest R2 value among
the indices of obesity in the 3 ethnicities (Table 5).
DISCUSSION
In the 3 ethnicities of middle-aged men, lipoprotein par-
ticle concentrations and size measured by nuclear magnetic
resonance spectroscopy were signiﬁcantly associated with
VAT. This result is consistent with our previous results in
U.S. white and Japanese middle-aged men [15]. Another
study also reported a similar association between lipopro-
tein and VAT in diabetic patients [25]. We also found that
the associations between SAT and lipoprotein subfractions
were less strong than the association between VAT and
lipoprotein subfractions was.
Associations of lipoproteins with SAT compared to
VAT
Only a few studies have examined the association of lipo-
protein particles with SAT versus with VAT. Although it is
not completely clear how SAT, compared with VAT, is
associated with CHD risk factors, increasing evidence
points to weaker associations between SAT and lipoprotein
particle concentrations, compared with those associations
for VAT. Fox et al. found SAT had a weaker correlation
with metabolic factors than VAT in Framingham cohorts
[14]. This weaker association with SAT versus VAT was
also shown in white and AA patients with type 2 diabetesGLOBAL HEART, VOL. 8, NO. 3, 2013
September 2013: 273-280
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September 2013: 273-280mellitus [25]. Our ﬁndings build on the increasing evi-
dence that SAT is less strongly, but signiﬁcantly, associated
with lipoprotein particle concentrations and numbers.
Associations of triglyceride-rich lipoproteins with
VAT
Our ﬁndings on the association between indices of obesity
and lipoprotein support the hypothesis that VAT has an
impact on the altered metabolism of triglyceride-rich li-
poprotein. Investigators have tried to explain the mecha-
nism for the associations between indices of obesity and
lipoprotein by looking at whether lipoprotein metabolism
is inﬂuenced by regional body fat, such as VAT, through
lipid metabolism in the liver. VAT favors access to the liver,
which enhances lipolytic activity in the liver and causes fat
accumulation [26]. Then, increased fat in the liver activates
cholesterol ester transport protein, which leads to an
increased exchange of triglycerides from VLDL to LDL and
HDL. Subsequently, the triglyceride-rich LDL and HDL are
converted into small and dense LDL and HDL, respec-
tively, by hepatic lipase. In this study, we found that VAT
was signiﬁcantly and positively associated with higher
particle concentrations of total and large VLDL and small
LDL, as well as signiﬁcantly inversely associated with large
HDL in the 3 ethnicities. We also observed the association
of VAT with lower average size of LDL (positively) and
HDL (inversely). Our results are consistent with the
triglyceride-rich lipoprotein metabolism theory in the 3
ethnicities.
Associations of triglyceride-rich lipoproteins with
WC, BMI, and SAT
We also found similar associations of WC and BMI with
large VLDL, small LDL, and lower average size of LDL and
HDL as seen in the associations of VAT with triglyceride-
rich lipoprotein subfractions in the 3 ethnicities in the
associations of SAT, WC, and BMI with triglyceride-rich
lipoprotein subfractions. Similar to VAT, SAT, WC, and
BMI support the notion that altered metabolism of
triglyceride-rich lipoprotein is affected by indices of
obesity, except in AA. AA showed signiﬁcant associations
of only WC and BMI with large VLDL, small LDL, and
large HDL. SAT did not show signiﬁcant associations with
the triglyceride-rich lipoprotein subfractions in AA. This
may be due to the smaller sample size of AA. Another
possibility is the difference in fat tissue distribution. Effect
of SAT on lipoprotein subfractions appears to be different
from that of VAT. The Framingham Heart Study reported
that increased SAT was signiﬁcantly associated with lower
triglyceride levels among the individuals who had high
VAT, whereas increased SAT was signiﬁcantly associated
with higher triglyceride levels among the individuals who
had low VAT [14]. The 3 ethnicities had signiﬁcantly
different fat tissue distributions. Therefore, AA, who had a
signiﬁcantly larger VAT, could explain the different asso-
ciations between triglyceride-rich lipoprotein subfractions277
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278and SAT. However, further investigations are needed to
explain how SAT, WC, and BMI are associated with
triglyceride-rich lipoprotein metabolism.Study strengths
We included population-based samples from 3 different
ethnicities, which allowed us to look at the cross-ethnic
consistency in the associations between each index of
obesity and lipoprotein subfractions. The measurements
for lipoprotein subfractions and for VAT, SAT, WC, and
BMI were standardized across the research centers. This
provided higher precision and accuracy in the measure-
ments. In addition, indices of obesity included multiple
variables: VAT, SAT, WC, and BMI, from the 3 different
ethnic groups. By comparing the associations among the
different indices of obesity, this study allowed us to analyze
the relative magnitude of associations among the different
indices of obesity.Study limitations
The smaller sample size for AA, compared with that of JA
and Koreans, gave the associations between indices of
obesity and lipoprotein subfractions less statistical power.
Although we randomly selected our study samples, our
samples may not necessarily be representative of the pop-
ulations. This also inﬂuenced the comparison of the
magnitude of associations among the ethnic groups. We
measured blood samples only at 1 time point and did not
take intraindividual variation [27] into account. Thus, it is
possible that the actual difference in lipid variables is
smaller than we reported. The study is cross-sectional in
design, which prevented the assessment of causality.
Clinical signiﬁcance of those differences among the ethnic
groups would be of interest for future studies. Our study
included only men and only individuals ages 40 to 49
years. Thus, the results may not be generalizable to other
age groups or women.CONCLUSIONS
All 3 ethnic groups showed signiﬁcant positive associations
of VAT with large VLDL and small LDL and a negative
association of VAT with large HDL. This study has further
expanded the evidence that VAT is signiﬁcantly associated
with both atherogenic and atheroprotective lipoprotein
particle concentrations to middle-aged JA, AA, and Korean
men. Our results also expanded the evidence that the as-
sociations of SAT with lipoprotein subfractions are weaker,
compared with those of VAT, in these ethnic groups.ACKNOWLEDGMENT
The authors especiallywould like to thank JessicaWhite,MS,
MLS, for her assistance in editing the English in this paper.GLOBAL HEART, VOL. 8, NO. 3, 2013
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